NEW YORK (AP) — A handful of deals helped nudge the stock market up in early trading Monday, despite a disappointing report on the economy.
Amgen surged 8 percent, the biggest gain in the Standard & Poor's 500 index, after the biotech giant said it plans to buy Onyx Pharmaceuticals for $10.4 billion. The deal, announced late Sunday, would give Amgen three approved cancer treatments and several others in clinical trials.
The S&P 500 index was up three points, or 0.2 percent, to 1,666 after the first hour of trading. Health-care companies led six of the 10 industry sectors in the S&P 500 slightly higher.
The Dow Jones industrial average edged up 15 points, or 0.1 percent, to 15,024. The Nasdaq composite index rose nine points, or 0.3 percent, at 3,667.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
